Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 2/20 | 0.64 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.64 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.64 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.64 |
| ▸ | LDHA | P00338 | 1/20 | 0.64 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.64 |
| ▸ | FBP1 | P09467 | 1/20 | 0.64 |
| ▸ | SRC | P12931 | 1/20 | 0.64 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.64 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.64 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.64 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.64 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.64 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.64 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.64 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.64 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24059946 | 1.00 | P2RY1 (0.64) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL20266309 | 1.00 | P2RY1 (0.64) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL20282730 | 1.00 | P2RY1 (0.64) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL16691022 | 0.93 | POLB (0.61) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL20428118 | 0.91 | P2RY1 (0.63) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL18107894 | 0.91 | POLB (0.58) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL1969290 | 0.91 | POLB (0.59) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL1969284 | 0.91 | POLB (0.59) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL20016487 | 0.91 | POLB (0.59) | P2RY1DNPH1PRKAB2TRPM2LDHA | |
| SCHEMBL25766886 | 0.90 | P2RY1 (0.62) | P2RY1DNPH1PRKAB2TRPM2LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024239431-A1 | METHOD FOR PHOSPHORYLATION OF NUCLEIC ACID AT 3' END AND LIBRARY CONSTRUCTION | 深圳华大智造科技股份有限公司 | 2024-11-28 | — | — | WO | claimed |
| CN-117137048-A | Flavor composition, food comprising the same, and method for increasing the flavor intensity of the umami taste of food | 马斯公司 | 2023-12-01 | — | — | CN | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| EP-3122756-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2015144282-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2015-10-01 | — | — | WO | claimed |
| EP-1624753-B1 | PURINERGIC MODULATION OF SMELL | UNIV UTAH RES FOUND (US) | 2012-01-25 | — | — | EP | claimed |
| EP-1595120-B1 | METAL COATED NANOCRYSTALLINE SILICON AS AN ACTIVE SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) SUBSTRATE | INTEL CORP (US) | 2009-12-30 | — | — | EP | claimed |
| EP-0929218-A4 | P2Y RECEPTOR ANTAGONISTS | UNIV NORTH CAROLINA (US) | 2001-05-16 | — | — | EP | claimed |
| EP-0929218-A2 | P2Y RECEPTOR ANTAGONISTS | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1999-07-21 | — | — | EP | claimed |
| WO-1998018430-A2 | P2Y RECEPTOR ANTAGONISTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1998-05-07 | — | — | WO | claimed |
| EP-0458971-B1 | INOSINE GUANOSINE KINASE | KYOWA HAKKO KOGYO KK (JP) | 1996-01-03 | — | — | EP | claimed |
| US-20260060965-A1 | MODULATING THE ACUTE FOREIGN BODY REACTION TO REDUCE STENOSIS | RES INSTITUTE AT NATIONWIDE CHILDREN’S HOSPITAL (US) | 2026-03-05 | — | — | US | disclosed |
| WO-2024239431-A1 | METHOD FOR PHOSPHORYLATION OF NUCLEIC ACID AT 3' END AND LIBRARY CONSTRUCTION | 深圳华大智造科技股份有限公司 | 2024-11-28 | — | — | WO | disclosed |
| EP-4403042-A2 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | Mars, Incorporated (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-3229612-B1 | USE OF FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS INC (US) | 2024-06-26 | — | — | EP | disclosed |
| WO-2001051490-A1 | METHANOCARBA CYCLOALKYL NUCLEOSIDE ANALOGUES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-07-19 | — | — | WO | disclosed |
| EP-0929218-A4 | P2Y RECEPTOR ANTAGONISTS | UNIV NORTH CAROLINA (US) | 2001-05-16 | — | — | EP | disclosed |
| EP-0929218-A2 | P2Y RECEPTOR ANTAGONISTS | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998018430-A2 | P2Y RECEPTOR ANTAGONISTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1998-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060965-A1 | MODULATING THE ACUTE FOREIGN BODY REACTION TO REDUCE STENOSIS | AGTR1, P2RY12, AGTR2 | P2RY1 7/4885DNPH1 2639/4885PRKAB2 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.